Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression.
Weidong Shi,Chenyue Zhang,Zhouyu Ning,Yongqiang Hua,Ye Li,Lianyu Chen,Luming Liu,Zhen Chen,Zhiqiang Meng +8 more
Reads0
Chats0
TLDR
Long non-coding RNA LINC00346 shows the ability to promote pancreatic cancer growth and gemcitabine resistance, which is in part mediated by antagonization of miR-188-3p and induction of BRD4.Abstract:
Long non-coding RNA LINC00346 has been recently suggested as a prognostic marker in pancreatic cancer. However, its biological function in pancreatic cancer has not yet been determined. In this study, we attempted to ascertain the role of LINC00346 in regulating the aggressiveness of pancreatic cancer. The effects of overexpression and knockdown of LINC00346 on the proliferation, cell cycle progression, apoptosis, and gemcitabine resistance were investigated. Bioinformatic analysis, luciferase reporter assay, and RNA immunoprecipitation assay were performed to search for potential microRNAs (miRs) that can interact with LINC00346. Overexpression of LINC00346 significantly enhanced the proliferation, colony formation, and tumorigenesis of pancreatic cancer cells. Conversely, knockdown of LINC00346 suppressed pancreatic cancer cell proliferation and caused a cell-cycle arrest at the G2/M-phase. Depletion of LINC00346 also enhanced gemcitabine sensitivity in pancreatic cancer cells both in vitro and in vivo. Mechanistic investigation revealed that LINC00346 acted as a sponge for miR-188-3p and blocked the repression of BRD4 by miR-188-3p in pancreatic cancer cells. Clinical evidence indicated a negative correlation between LINC00346 and miR-188-3p in pancreatic cancer specimens. Rescue experiments showed that LINC00346 attenuated the growth-suppressing and chemosensitizing effects of miR-188-3p on pancreatic cancer cells. In addition, silencing of BRD4 significantly inhibited LINC00346-induced pancreatic cancer cell proliferation and colony formation. LINC00346 shows the ability to promote pancreatic cancer growth and gemcitabine resistance, which is in part mediated by antagonization of miR-188-3p and induction of BRD4. Targeting LINC00346 may improve gemcitabine-based therapeutic efficacy.read more
Citations
More filters
Journal ArticleDOI
Degradation of proteins by PROTACs and other strategies.
TL;DR: Recent meaningful research of PROTAC is summarized, including the types of degradation proteins, preliminary biological data in vitro and in vivo, and new E3 ubiquitin ligases, which strongly proved the value of the PROTAC strategy.
Journal ArticleDOI
The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential.
TL;DR: The current review discusses the potential role and molecular mechanism of lncRNA in regulating the prominent hallmarks of cancer including abnormal growth, survival, metastasis, and drug-resistance in PDAC and highlights the possible application of various therapeutic strategies.
Journal ArticleDOI
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
Wenxiao Jiang,Jun Xia,Shangdan Xie,Ruanmin Zou,Shuya Pan,Zhiwei Wang,Zhiwei Wang,Yehuda G. Assaraf,Xueqiong Zhu +8 more
TL;DR: The current review succinctly elucidate the molecular mechanisms by which lncRNAs modulate their downstream targets to mediate cancer chemoresistance and may provide a significant basis for the future conquering of Chemoresistance via targeting lnc RNAs in cancer therapeutics.
Journal ArticleDOI
Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation
Yuhao Luo,Siting Zheng,Qianying Wu,Jianhua Wu,Rui Zhou,Chunling Wang,Zhenzhen Wu,Xiaoxiang Rong,Na Huang,Li Sun,Jianping Bin,Yulin Liao,Min Shi,Wangjun Liao +13 more
TL;DR: Wang et al. as mentioned in this paper found that EIF3J-DT activated autophagy and induced drug resistance in gastric cancer cells by targeting ATG14, and this was closely associated with patient prognosis.
Journal ArticleDOI
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
TL;DR: A number of compounds are described, including curcumin, genistein, resveratrol, quercetin, and salinomycin, which may modulate the expression of lncRNAs and enhance chemosensitivity in pancreatic cancers.
References
More filters
Journal ArticleDOI
Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method
TL;DR: The 2-Delta Delta C(T) method as mentioned in this paper was proposed to analyze the relative changes in gene expression from real-time quantitative PCR experiments, and it has been shown to be useful in the analysis of realtime, quantitative PCR data.
Journal ArticleDOI
Cancer statistics, 2018
TL;DR: The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak.
Journal ArticleDOI
Targeting noncoding RNAs in disease
TL;DR: The continued improvement of innovative RNA modifications and delivery entities, such as nanoparticles, will aid in the development of future RNA-based therapeutics for a broader range of chronic diseases.
Journal ArticleDOI
Emerging roles of long non-coding RNA in cancer.
TL;DR: This article aims to outline different cancer‐associated lncRNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations.